NCT02457247 - Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. | Biotech Hunter

Enrollment

276

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Calcium and Vitamin D Deficiencies

Interventions

DRUG

Calcichew D3

Calcichew D3 500/400 (Calcium 500 mg/400 IU Vitamin D3) Calcichew D3 500/800 (Calcium 500 mg/800 IU Vitamin D3)

DRUG

Adcal-D3

Adcal-D3 (Calcium 600mg/400 IU Vitamin D3)

DRUG

Kalcipos-D

Kalcipos-D (Calcium 500mg/800 IU Vitamin D3)

Trial Locations (9)

Berlin

Bochum

Frankfurt

Leipzig

Reading

Birmingham

Chorley

Liverpool

Manchester